Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02731729 |
|---|---|
| Brief Title: | Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy |
| First Submitted : | April 4, 2016 |
| First Submitted that Met QC Criteria : | April 6, 2016 |
| First Posted : | April 7, 2016 (Estimate) |
| Results First Submitted : | January 12, 2021 |
| Results First Submitted that Met QC Criteria : | February 2, 2021 |
| Results First Posted : | February 21, 2021 |
| Last Update Submitted that Met QC Criteria : | December 21, 2022 |
| Last Update Posted : | December 23, 2022 |